Db. Knoerzer et al., COLLAGEN-INDUCED ARTHRITIS IN THE BB-RAT - PREVENTION OF DISEASE BY TREATMENT WITH CTLA-4-IG, The Journal of clinical investigation, 96(2), 1995, pp. 987-993
Antigen-specific T cell activation requires two independent signalling
events, one mediated through T cell receptor engagement by the antige
n-presenting cell-expressed peptide/class II major histocompatibility
complex, and the second through the cognate interactions of costimulat
ory molecules expressed on the T cell and antigen-presenting cell, The
re is evidence from in vitro and in vivo experimental systems suggesti
ng that the CD28/B7 costimulatory pathway is crucial for induction of
maximal T cell proliferation and T helper-B cell collaboration for IgG
production, This pathway can be blocked by CTLA-4-Ig, a soluble form
of CTLA-4 which binds with high avidity to the CD28 ligands, B7-1 and
B7-2, Here, we show that CTLA-4-Ig treatment prevents clinical and his
tological manifestations of disease in a collagen-induced arthritis mo
del of rheumatoid arthritis in the diabetes resistant BB/Wor rat, when
therapy is initiated before immunization with bovine type IP collagen
(BIIC), Anti-BIIC antibody titers are reduced in CTLA-4-Ig-treated ra
ts compared to diseased control animals, Histologically, joints from C
TLA-4-Ig-treated animals show no histological abnormalities, in contra
st to control antibody-treated animals, which show complete erosion of
the articular cartilage and bone, Despite the efficacy of CTLA-4-Ig i
n preventing clinical and histological signs of arthritis and reducing
antibody responses to BIIC, delayed type hypersensitivity responses t
o collagen 18 d or more after CTLA-4-Ig treatment ends are similar in
CTLA-4-Ig-treated and untreated rats, suggesting that the prolonged di
sease suppression observed does not result from induction of T cell an
ergy.